Framingham, MA, United States of America

Mary C Pomeroy

This inventor holds 1 USPTO granted patent. Top assignee: Nova Biomedical Corporation. Active years: 2011.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mary C Pomeroy: Innovator in Biomolecule Quantification

Introduction

Mary C Pomeroy is a notable inventor based in Framingham, MA (US). She has made significant contributions to the field of biomolecule quantification through her innovative work. Her expertise and dedication have led to the development of a unique patent that enhances the efficiency of biomolecule assays.

Latest Patents

Mary C Pomeroy holds a patent for a "Rapid quantification assay involving concentrated and ligand-coated gold colloid." This invention includes a concentrated and ligand-coated gold colloid and a method for its preparation. Additionally, it discloses a rapid biomolecule quantification assay that utilizes the concentrated gold colloid, along with an apparatus designed for performing the assay. This patent showcases her ability to merge chemistry and technology for practical applications.

Career Highlights

Mary is currently employed at Nova Biomedical Corporation, where she continues to push the boundaries of innovation in her field. Her work at Nova Biomedical Corporation has allowed her to collaborate with other talented professionals, further enhancing her contributions to the industry.

Collaborations

Some of her notable coworkers include Jeffrey C Chien and Catherine A Saltalamacchia. Their collaborative efforts have likely played a role in advancing the research and development initiatives at Nova Biomedical Corporation.

Conclusion

Mary C Pomeroy is a distinguished inventor whose work in biomolecule quantification has made a significant impact. Her patent and ongoing contributions at Nova Biomedical Corporation highlight her commitment to innovation and excellence in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…